Literature DB >> 16340241

Identification of differentially expressed genes between fetal and adult mouse kidney: candidate gene in kidney development.

Isabelle Guinobert1, Mélanie Viltard, David Piquemal, Jean-Marc Elalouf, Jacques Marti, Martine Lelièvre-Pégorier.   

Abstract

BACKGROUND: The kidney development involves a wide variety of developmental processes requiring a lot of genes expressed in a sequential manner. The aim of the present study is to identify new genes involved in these processes.
METHODS: To obtain a view of the mouse embryonic kidney transcriptome we used the SADE method, which allows large-scale quantitative gene expression measurements.
RESULTS: 7,689 tags were sequenced from our library. Among the 4,507 unique transcripts yielded, 64% correspond to known genes, 22% ESTs, 12% unidentified genes. 472 genes were differentially expressed as compared to published adult kidney library. Among these, we identified several candidate genes and focused on a particular one: thymosin beta4 (Tbeta4), an actin-sequestering protein more highly expressed in fetal kidney. First we studied the in vivo expression patterns of Tbeta4 transcript during kidney development. Tbeta4 increases throughout the kidney development and remains high during active nephrogenesis. Moreover, the spatial distribution of Tbeta4 mRNA was analysed and reveals that during active nephrogenesis (i.e., 18 dpc) Tbeta4 is localised in differentiating glomeruli. In adult kidney, Tbeta4 remains expressed in podocytes and collecting ducts.
CONCLUSION: Our results provide the first demonstration of Tbeta4 production in vivo by embryonic kidney and further show that Tbeta4 is implicated in kidney organogenesis. 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340241     DOI: 10.1159/000090054

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  4 in total

1.  An extensive genetic program occurring during postnatal growth in multiple tissues.

Authors:  Gabriela P Finkielstain; Patricia Forcinito; Julian C K Lui; Kevin M Barnes; Rose Marino; Sami Makaroun; Vina Nguyen; Jacob E Lazarus; Ola Nilsson; Jeffrey Baron
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

2.  Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice.

Authors:  William J Mason; Daniyal J Jafree; Gideon Pomeranz; Maria Kolatsi-Joannou; Antje K Rottner; Sabrina Pacheco; Dale A Moulding; Anja Wolf; Christian Kupatt; Claire Peppiatt-Wildman; Eugenia Papakrivopoulou; Paul R Riley; David A Long; Elisavet Vasilopoulou
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

3.  Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract.

Authors:  S Nemolato; T Cabras; M U Fanari; F Cau; D Fanni; C Gerosa; B Manconi; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2010-10-13       Impact factor: 3.188

4.  Loss of endogenous thymosin β4 accelerates glomerular disease.

Authors:  Elisavet Vasilopoulou; Maria Kolatsi-Joannou; Maja T Lindenmeyer; Kathryn E White; Michael G Robson; Clemens D Cohen; Neil J Sebire; Paul R Riley; Paul J Winyard; David A Long
Journal:  Kidney Int       Date:  2016-08-26       Impact factor: 10.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.